Trellis Bioscience's Series C - II Round

Trellis Bioscience raised a round of funding on August 24, 2009.

Trellis Bioscience, Inc. is a private, venture-funded, antibody company focused on the discovery and development of unique therapeutic antibodies from human B cells. Trellis developed its patented Cel…

Articles about Trellis Bioscience's Series C - II Round: